These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11328659)

  • 1. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies.
    Khan A; Benboubetra M; Sayyed PZ; Ng KW; Fox S; Beck G; Benter IF; Akhtar S
    J Drug Target; 2004 Jul; 12(6):393-404. PubMed ID: 15545089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation and release of vancomycin from poly(D,L-lactide-co-glycolide) microspheres.
    Atkins TW; Peacock SJ; Yates DJ
    J Microencapsul; 1998; 15(1):31-44. PubMed ID: 9463805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
    De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
    J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS; Whateley TL
    J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies.
    Wang SH; Zhang LC; Lin F; Sa XY; Zuo JB; Shao QX; Chen GS; Zeng S
    Int J Pharm; 2005 Sep; 301(1-2):217-25. PubMed ID: 16040213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies.
    Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM
    J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled delivery of antisense oligodeoxynucleotide from cationically modified phosphorylcholine polymer films.
    Zhang Z; Cao X; Zhao X; Withers SB; Holt CM; Lewis AL; Lu JR
    Biomacromolecules; 2006 Mar; 7(3):784-91. PubMed ID: 16529415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release.
    Martínez-Sancho C; Herrero-Vanrell R; Negro S
    Int J Pharm; 2006 Dec; 326(1-2):100-6. PubMed ID: 16945492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
    Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
    J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of microspheres with surface amino groups from blends of Poly(Lactide-co-glycolide) and Poly(epsilon-CBZ-L-lysine) and use for encapsulation.
    Zheng J; Hornsby PJ
    Biotechnol Prog; 1999; 15(4):763-7. PubMed ID: 10441368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential approach for decreasing the burst effect of protein from PLGA microspheres.
    Fu K; Harrell R; Zinski K; Um C; Jaklenec A; Frazier J; Lotan N; Burke P; Klibanov AM; Langer R
    J Pharm Sci; 2003 Aug; 92(8):1582-91. PubMed ID: 12884245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
    Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
    Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet.
    Manome Y; Kobayashi T; Mori M; Suzuki R; Funamizu N; Akiyama N; Inoue S; Tabata Y; Watanabe M
    Anticancer Res; 2006; 26(5A):3317-26. PubMed ID: 17094447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain.
    Kilic AC; Capan Y; Vural I; Gursoy RN; Dalkara T; Cuine A; Hincal AA
    J Microencapsul; 2005 Sep; 22(6):633-41. PubMed ID: 16401579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery.
    Gomes dos Santos AL; Bochot A; Doyle A; Tsapis N; Siepmann J; Siepmann F; Schmaler J; Besnard M; Behar-Cohen F; Fattal E
    J Control Release; 2006 May; 112(3):369-81. PubMed ID: 16644054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.